Edition:
United Kingdom

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

3.01USD
19 Jan 2018
Change (% chg)

$-0.11 (-3.53%)
Prev Close
$3.12
Open
$3.01
Day's High
$3.06
Day's Low
$2.98
Volume
48,008
Avg. Vol
60,632
52-wk High
$6.63
52-wk Low
$2.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.122
Jun '17 0.00 -0.087
Mar '17 0.00 -0.038
Dec 0.00 -0.082
FY 2016 Sep '16 0.00 -0.182
Jun '16 0.00 -0.063
Mar '16 0.00 -0.058
Dec 0.00 -0.116
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Sep-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Year Ending Sep-18 2 -0.40 -0.35 -0.44 -0.69
Year Ending Sep-19 1 -0.48 -0.48 -0.48 -0.70
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.70 32.90
P/E High - Last 5 Yrs. -- 302.09 46.03
P/E Low - Last 5 Yrs. -- 94.18 24.39
Beta 1.01 0.88 0.89
Price to Sales (TTM) -- 94.43 5.45
Price to Book (MRQ) 7.57 13.36 5.38
Price to Tangible Book (MRQ) 7.57 13.64 6.89
Price to Cash Flow (TTM) -- 72.87 23.43
% Owned Institutions 24.62 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.22 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 401.22 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 71.05 5.44
Sales - 5 Yr. Growth Rate -- 33.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -38.62 29.49 19.33
EPS (TTM) vs TTM 1 Yr. Ago 9.14 -- --
EPS - 5 Yr. Growth Rate -- 40.21 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.33 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 17.09 5.23 2.97
LT Debt to Equity (MRQ) 0.00 21.05 12.10
Total Debt to Equity (MRQ) 0.00 22.61 16.38
Interest Coverage (TTM) -- -102.06 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.21 54.76
Gross Margin - 5 Yr. Avg. -- 52.54 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -239.51 15.33
Operating Margin (TTM) -- -519.41 7.60
Operating Margin - 5 Yr. Avg. -- -256.70 10.79
Pre-Tax Margin (TTM) -- -494.96 8.38
Pre-Tax Margin - 5 Yr. Avg. -- -256.63 11.19
Net Profit Margin (TTM) -- -496.46 4.70
Net Profit Margin - 5 Yr. Avg. -- -259.85 7.50
Effective Tax Rate (TTM) -- 23.29 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.77 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,318,311 855,725,045
Net Income/Employee (TTM) -1,481,687 3,079,098 100,665,187
Receivable Turnover (TTM) -- 20.24 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.28 0.09 10.97
Return on Assets - 5 Yr. Avg. -173.84 0.51 12.39
Return on Investment (TTM) -95.21 3.19 14.40
Return on Investment - 5 Yr. Avg. -289.36 3.64 16.20
Return on Equity (TTM) -95.21 4.52 16.09
Return on Equity - 5 Yr. Avg. -476.42 8.98 17.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Anavex Life Sciences Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 22.88%
# of Holders: 93
Total Shares Held: 10,116,737
3 Mo. Net Change: -2,121
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 3
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.